Literature DB >> 19005718

Fontan patient with plastic bronchitis treated successfully using aerosolized tissue plasminogen activator: a case report and review of the literature.

Thomas B Do1, James M Chu, Farhouch Berdjis, Nick G Anas.   

Abstract

Plastic bronchitis is an uncommon condition characterized by the production of large pale bronchial casts that obstruct the tracheobronchial tree. The cellular content, cohesiveness, and often rubber-like consistency distinguish bronchial casts from the usual mucus plugs found with such disease states as asthma. Plastic bronchitis can be found secondary to many conditions, and a simplified classification scheme organizes it into two groups: an inflammatory type consisting of casts with an eosinophilic inflammatory infiltrate and an acellular type with a predominance of fibrin distinguished by its relative lack of cellular infiltrate, its mucin predominance, and its appearance only in children with congenital cyanotic heart disease. This report describes a 5-year-old girl who experienced plastic bronchitis 3 months after a Fontan procedure for hypoplastic left heart syndrome that was treated successfully with aerosolized tissue plasminogen activator.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005718     DOI: 10.1007/s00246-008-9312-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  12 in total

1.  Plastic bronchitis occurring late after the Fontan procedure in a child: treatment with stent implantation in the left pulmonary artery.

Authors:  Ebru Yalçin; Ugur Ozçelik; Alpay Celiker
Journal:  J Invasive Cardiol       Date:  2005-06       Impact factor: 2.022

2.  Bronchial casts in children with cardiopathies: the role of pulmonary lymphatic abnormalities.

Authors:  J Languepin; P Scheinmann; B Mahut; M Le Bourgeois; F Jaubert; F Brunelle; D Sidi; J de Blic
Journal:  Pediatr Pulmonol       Date:  1999-11

3.  Fenestration of the Fontan circuit as treatment for plastic bronchitis.

Authors:  J Wilson; J Russell; W Williams; L Benson
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

4.  Plastic bronchitis; a serious complication of the Fontan operation.

Authors:  A Tzifa; M Robards; J M Simpson
Journal:  Int J Cardiol       Date:  2005-06-08       Impact factor: 4.164

5.  Plastic bronchitis occurring late after the Fontan procedure: treatment with aerosolized urokinase.

Authors:  M W Quasney; K Orman; J Thompson; J C Ring; M Salim; R A Schoumacher; D Watson; W Novick; S R Deitcher; R Joyner
Journal:  Crit Care Med       Date:  2000-06       Impact factor: 7.598

6.  Long-term treatment of plastic bronchitis with aerosolized tissue plasminogen activator in a Fontan patient.

Authors:  Martin K Wakeham; Andrew H Van Bergen; Luis E Torero; Javeed Akhter
Journal:  Pediatr Crit Care Med       Date:  2005-01       Impact factor: 3.624

Review 7.  Treatment of plastic bronchitis in a Fontan patient with tissue plasminogen activator: a case report and review of the literature.

Authors:  John M Costello; David Steinhorn; Susanna McColley; Mark E Gerber; Sulekha P Kumar
Journal:  Pediatrics       Date:  2002-04       Impact factor: 7.124

Review 8.  Bronchial casts in children: a proposed classification based on nine cases and a review of the literature.

Authors:  M Seear; H Hui; F Magee; D Bohn; E Cutz
Journal:  Am J Respir Crit Care Med       Date:  1997-01       Impact factor: 21.405

9.  The bronchial cast syndrome after the fontan procedure: further evidence of its etiology.

Authors:  C J McMahon; M R Nihill; A Reber
Journal:  Cardiol Young       Date:  2001-05       Impact factor: 1.093

10.  Resolution of plastic bronchitis with atrial pacing in a patient with fontan physiology.

Authors:  B J Barber; G H Burch; D Tripple; S Balaji
Journal:  Pediatr Cardiol       Date:  2003-10-13       Impact factor: 1.655

View more
  21 in total

Review 1.  Fungi in Mucoobstructive Airway Diseases.

Authors:  Evan Li; Cameron T Landers; Hui-Ying Tung; J Morgan Knight; Zachary Marshall; Amber U Luong; Antony Rodriguez; Farrah Kheradmand; David B Corry
Journal:  Ann Am Thorac Soc       Date:  2018-11

2.  A multifaceted approach to the management of plastic bronchitis after cavopulmonary palliation.

Authors:  Catherine M Avitabile; David J Goldberg; Kathryn Dodds; Yoav Dori; Chitra Ravishankar; Jack Rychik
Journal:  Ann Thorac Surg       Date:  2014-05-17       Impact factor: 4.330

Review 3.  Successful management of plastic bronchitis in a child post Fontan: case report and literature review.

Authors:  Paul Do; Inderpal Randhawa; Terry Chin; Kourosh Parsapour; Eliezer Nussbaum
Journal:  Lung       Date:  2012-03-20       Impact factor: 2.584

Review 4.  Four decades of Fontan palliation.

Authors:  Marc R de Leval; John E Deanfield
Journal:  Nat Rev Cardiol       Date:  2010-06-29       Impact factor: 32.419

5.  Strategies to Prevent Cast Formation in Patients with Plastic Bronchitis Undergoing Heart Transplantation.

Authors:  John J Parent; Robert K Darragh; Jeffrey G Gossett; Thomas D Ryan; Chet R Villa; Angela Lorts; John L Jefferies; Jeffrey A Towbin; Clifford Chin
Journal:  Pediatr Cardiol       Date:  2017-01-19       Impact factor: 1.655

Review 6.  Airway fibrinogenolysis and the initiation of allergic inflammation.

Authors:  Valentine Ongeri Millien; Wen Lu; Garbo Mak; Xiaoyi Yuan; J Morgan Knight; Paul Porter; Farrah Kheradmand; David B Corry
Journal:  Ann Am Thorac Soc       Date:  2014-12

7.  Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction.

Authors:  Livia A Veress; Tara B Hendry-Hofer; Joan E Loader; Jacqueline S Rioux; Rhonda B Garlick; Carl W White
Journal:  Am J Respir Cell Mol Biol       Date:  2013-04       Impact factor: 6.914

8.  Pharmacotherapy challenges of Fontan-associated plastic bronchitis: a rare pediatric disease.

Authors:  Kristina Brooks; Regine L Caruthers; Kurt R Schumacher; Kathleen A Stringer
Journal:  Pharmacotherapy       Date:  2013-05-17       Impact factor: 4.705

9.  Safety of prolonged, repeated administration of a pulmonary formulation of tissue plasminogen activator in mice.

Authors:  Nicholas P Lackowski; Josh E Pitzer; Meghan Tobias; Zachary Van Rheen; Rajiv Nayar; Mitra Mosharaff; Kathleen A Stringer
Journal:  Pulm Pharmacol Ther       Date:  2009-10-29       Impact factor: 3.410

10.  Evaluating failing Fontans for heart transplantation: predictors of death.

Authors:  Eric R Griffiths; Aditya K Kaza; Moritz C Wyler von Ballmoos; Hugo Loyola; Anne Marie Valente; Elizabeth D Blume; Pedro del Nido
Journal:  Ann Thorac Surg       Date:  2009-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.